Sheng Morgan 4
4 · Prevail Therapeutics Inc. · Filed Nov 18, 2019
Insider Transaction Report
Form 4
Sheng Morgan
Director
Transactions
- Award
Stock Option (Right to Buy)
2019-11-15+20,000→ 20,000 totalExercise: $10.62Exp: 2029-11-15→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The shares underlying the option will vest in 36 equal monthly installments beginning on December 15, 2019, subject to the Reporting Person's continuous service to the Issuer on each such date.